Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$27,239,023
+$3,206,378 QoQ
Shares Held
108,246
-2.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#517
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SILVERCREST ASSET MANAGEMENT GROUP LLC holds $298,590,573 across 11 Drug Manufacturers - General names. ABBV ranks #4 (9.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
546,930 | $138,903,812 | |
| 2 | MRK |
Merck & Co., Inc.
|
253,643 | $32,593,125 | |
| 3 | AMGN |
Amgen Inc
|
87,964 | $31,853,523 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
108,246 | $27,239,023 | |
| 5 | AZN |
Astrazeneca PLC
|
134,020 | $25,412,872 | |
| 6 | GSK |
GSK plc
|
313,984 | $16,459,041 | |
| 7 | LLY |
ELI LILLY & Co
|
13,666 | $16,391,411 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
66,843 | $3,851,493 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,239,023 | 108,246 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $24,032,645 | 110,500 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $28,570,389 | 125,040 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $28,916,567 | 124,888 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $23,293,639 | 125,491 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $27,435,177 | 130,943 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $22,339,022 | 125,712 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $29,217,758 | 147,953 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $25,449,280 | 148,375 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $27,775,166 | 152,527 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $26,643,372 | 171,926 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $25,849,985 | 173,420 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $23,969,679 | 177,909 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $29,115,464 | 182,691 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $29,678,222 | 183,641 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $24,989,230 | 186,195 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $28,629,892 | 186,928 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $30,968,197 | 191,032 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $25,927,069 | 191,485 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $20,966,044 | 194,364 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $22,100,981 | 196,209 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $21,146,837 | 195,406 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $21,239,594 | 198,223 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $17,662,348 | 201,648 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $20,476,322 | 208,559 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $15,009,887 | 197,006 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||